LSV Asset Management
VNDA icon

LSV Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

LSV Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,768
Closed -$29K – 880
2023
Q4 		$29K Hold
6,768
– – ﹤0.01% 861
2023
Q3 		$29K Sell
6,768
-15,332
-69% -$85.2K ﹤0.01% 855
2023
Q2 		$146K Sell
22,100
-51,100
-70% -$328K ﹤0.01% 848
2023
Q1 		$497K Hold
73,200
– – ﹤0.01% 736
2022
Q4 		$541K Hold
73,200
– – ﹤0.01% 715
2022
Q3 		$723K Sell
73,200
-55,600
-43% -$587K ﹤0.01% 676
2022
Q2 		$1.4M Sell
128,800
-2,136,437
-94% -$22.1M ﹤0.01% 639
2022
Q1 		$25.6M Buy
2,265,237
+4,755
+0.2% +$62.5K 0.05% 306
2021
Q4 		$35.5M Buy
2,260,482
+131,385
+6% +$2.29M 0.06% 269
2021
Q3 		$36.5M Buy
2,129,097
+279,049
+15% +$4.89M 0.07% 278
2021
Q2 		$39.8M Buy
1,850,048
+531,066
+40% +$9.5M 0.07% 271
2021
Q1 		$19.8M Buy
1,318,982
+937,565
+246% +$15.2M 0.03% 375
2020
Q4 		$5.01M Buy
+381,417
New +$4.59M 0.01% 555

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management's VNDA Position: Q1 2024 in Review

LSV Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2024, closing a stake of 6,768 shares — an estimated $29K sold.

LSV Asset Management first reported a position in VNDA in Q4 2020 and held it in 13 quarters. The position peaked at $39.8M in Q2 2021. 144 funds tracked by Wall St. Rank hold VNDA as of Q1 2024.

  • LSV Asset Management reported no remaining Vanda Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • LSV Asset Management sold 6,768 Vanda Pharmaceuticals shares in Q1 2024, an estimated $29K.
  • LSV Asset Management first reported a position in Vanda Pharmaceuticals in Q4 2020 and held it in 13 quarters.
  • LSV Asset Management's Vanda Pharmaceuticals position peaked at $39.8M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2024.

Based on LSV Asset Management's 13F filing for Q1 2024, filed 6 May 2024.